Prelude Capital Management, LLC Bausch Health Companies Inc. Call Options Transaction History

Prelude Capital Management, LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 16, 2022	SELL	$21.6 - $27.79 $3.35 Million - $4.31 Million	-155,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$23.0 - $29.01 $862,500 - $1.09 Million	-37,500 Reduced 19.48%	155,000 $4.28 Million
Q3 2021 Nov 15, 2021	BUY	$25.04 - $30.06 $1.74 Million - $2.09 Million	69,400 Added 56.38%	192,500 $5.36 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $1.7 Million - $2.02 Million	-61,900 Reduced 33.46%	123,100 $3.67 Million
Q1 2021 May 17, 2021	BUY	$21.37 - $34.38 $1.98 Million - $3.18 Million	92,600 Added 100.22%	185,000 $5.87 Million
Q4 2020 Feb 16, 2021	BUY	$15.31 - $21.12 $1.41 Million - $1.95 Million	92,400 New	92,400 $1.92 Million
Q3 2020 Nov 16, 2020	SELL	$14.88 - $20.13 $11,904 - $16,104	-800 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$13.31 - $20.51 $622,908 - $959,868	-46,800 Reduced 98.32%	800 $15,000
Q1 2020 May 15, 2020	BUY	$12.98 - $30.25 $607,464 - $1.42 Million	46,800 Added 5850.0%	47,600 $738,000
Q4 2019 Feb 14, 2020	BUY	$18.89 - $31.89 $15,112 - $25,512	800 New	800 $24,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.